Literature DB >> 25495880

Vitiligo treatment update.

Benjamin S Daniel1, Richard Wittal.   

Abstract

Vitiligo is a common depigmenting disease that can affect the skin and mucosal surfaces. Various treatments have been used over the years with varying repigmentation rates. This review looks at the evidence of commonly used therapies for vitiligo.
© 2014 The Australasian College of Dermatologists.

Entities:  

Keywords:  management; treatment; vitiligo

Mesh:

Substances:

Year:  2014        PMID: 25495880     DOI: 10.1111/ajd.12256

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  4 in total

1.  Epidermal skin grafting in vitiligo: a pilot study.

Authors:  Agata Janowska; Valentina Dini; Salvatore Panduri; Michela Macchia; Teresa Oranges; Marco Romanelli
Journal:  Int Wound J       Date:  2016-09       Impact factor: 3.315

2.  Evaluation of treatment response to autologous transplantation of noncultured melanocyte/keratinocyte cell suspension in patients with stable vitiligo.

Authors:  Mariana Gontijo Ramos; Daniel Gontijo Ramos; Camila Gontijo Ramos
Journal:  An Bras Dermatol       Date:  2017 May-Jun       Impact factor: 1.896

3.  Repigmentation of Tenacious Vitiligo on Apremilast.

Authors:  Sara B Huff; Lorie D Gottwald
Journal:  Case Rep Dermatol Med       Date:  2017-11-06

Review 4.  Recent Progress and Future Directions: The Nano-Drug Delivery System for the Treatment of Vitiligo.

Authors:  Ming-Chen Sun; Xiao-Ling Xu; Xue-Fang Lou; Yong-Zhong Du
Journal:  Int J Nanomedicine       Date:  2020-05-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.